No profile data available.
Aspire Biopharma Holdings, Inc. (ASBP) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Estero, United States.
It reported revenue of $6,202 for fiscal year 2025, and net income of -$24.48 million. Its market capitalization was $11.64 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Aspire-Lakewood Holdings, Inc. develops sublingual drug delivery technology and manufactures automotive and industrial control systems.
Aspire Biopharma reported $6,202 in revenue for fiscal year 2025.
$11.64 million as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Aida Pharmaceuticals, Inc. (AIDA), Fluent Corp. (CNTMF), GT Biopharma, Inc. (GTBP), Aptorum Group Limited (APM).